{"id":"F2018L01177","name":"Statement of Principles concerning sinusitis (Balance of Probabilities) (No. 74 of 2018)","slug":"statement-of-principles-concerning-sinusitis-balance-of-probabilities-no-74-of-2018","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":439732,"registerId":"F2018L01177-fast-fetch-1775955641957","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning sinusitis (Balance of Probabilities) (No. 74 of 2018)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n\n\n \n\nStatement of Principles\n\nconcerning\n\nSINUSITIS (Balance of Probabilities)\n\n(No. 74 of 2018)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(3) of the Veterans' Entitlements Act 1986.\n\n \n\nDated 24 August 2018\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
|\n| --- |\n|
Professor Nicholas Saunders AO
Chairperson
|\n\n\n \n\n \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1 Name\n\nThis is the Statement of Principles concerning sinusitis (Balance of Probabilities) (No. 74 of 2018).\n\n2 Commencement\n\n This instrument commences on 24 September 2018.\n\n3 Authority\n\nThis instrument is made under subsection 196B(3) of the Veterans' Entitlements Act 1986.\n\n4 Repeal\n\nThe Statement of Principles concerning sinusitis No. 10 of 2010 (Federal Register of Legislation No. F2010L00554) made under subsection 196B(3) of the VEA is repealed.\n\n5 Application\n\nThis instrument applies to a claim to which section 120B of the VEA or section 339 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about sinusitis and death from sinusitis.\n\nMeaning of sinusitis\n\n(2) For the purposes of this Statement of Principles, sinusitis (also known as rhinosinusitis):\n\n(a) means inflammation of the nasal cavity and the paranasal sinuses; and\n\n(b) includes acute sinusitis and chronic sinusitis.\n\nNote: Sinusitis is characterised by the following signs and symptoms: nasal blockage or congestion, nasal discharge (anterior or postnasal drip), facial pain or pressure, or reduction or loss of smell, and fluid within the sinuses.\n\n(3) While sinusitis attracts ICD‑10‑AM code J01 or J32, in applying this Statement of Principles the meaning of sinusitis is that given in subsection (2).\n\n(4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.\n\nDeath from sinusitis\n\n(5) For the purposes of this Statement of Principles, sinusitis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's sinusitis.\n\nNote: terminal event is defined in the Schedule 1 – Dictionary.\n\n8 Basis for determining the factors\n\nOn the sound medical‑scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that sinusitis and death from sinusitis can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must exist before it can be said that, on the balance of probabilities, sinusitis or death from sinusitis is connected with the circumstances of a person's relevant service:\n\n(1) having impaired drainage of the sinus at the time of the clinical onset of sinusitis;\n\nNote: impaired drainage of the sinus is defined in the Schedule 1 - Dictionary. \n\n(2) having a viral, bacterial or fungal respiratory tract infection at the time of the clinical onset of sinusitis;\n\n(3) being in an immunocompromised state as specified at the time of the clinical onset of sinusitis;\n\nNote: immunocompromised state as specified is defined in the Schedule 1 - Dictionary. \n\n(4) having a specified medical condition at the time of the clinical onset of sinusitis;\n\nNote: specified medical condition is defined in the Schedule 1 - Dictionary.\n\n(5) undergoing a course of therapeutic radiation for cancer, where the nasal cavity and paranasal sinuses were in the field of radiation, before the clinical onset of sinusitis;\n\n(6) smoking at least one pack-year of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of sinusitis, and:\n\n(a) smoking commenced at least one year before the clinical onset of sinusitis; and\n\n(b) where smoking has ceased, the clinical onset of sinusitis has occurred within three months of smoking cessation;\n\nNote: pack-year of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary. \n\n(7) being exposed to second-hand smoke:\n\n(a) for at least 1 000 hours before the clinical onset of sinusitis; and\n\n(b) where the first exposure to second-hand smoke commenced at least one year before the clinical onset of sinusitis; and\n\n(c) where the last exposure to second-hand smoke occurred within the three months before the clinical onset of sinusitis;\n\nNote: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary. \n\n(8) inhaling a drug or irritant substance which results in:\n\n(a) acute nasal symptoms or signs within 48 hours of the inhalation; and\n\n(b) scarring or erosion of the nasal or sinus mucosa;\n\nbefore the clinical onset of sinusitis;\n\nNote 1: Examples of drugs include cocaine, lidocaine, methylphenidate and narcotics.\n\nNote 2: Examples of irritant substances include gases (ammonia, chlorine, mustard, nitrogen dioxide, sulphur dioxide), powdered solids (aspirin, baking soda, levamisole, capsules, tablets, pills) and lewisite.\n\nNote 3: Examples of acute nasal symptoms or signs include rhinorrhoea, and the inflammation, oedema, ulceration or haemorrhage of the nasal mucosa.\n\n(9) for sinusitis affecting the maxillary sinus only, having a specified dental condition affecting the tissues adjacent to the affected maxillary sinus at the time of the clinical onset of sinusitis;\n\nNote: specified dental condition is defined in the Schedule 1 - Dictionary. \n\n(10) having impaired drainage of the sinus at the time of the clinical worsening of sinusitis;\n\nNote: impaired drainage of the sinus is defined in the Schedule 1 - Dictionary. \n\n(11) having a viral, bacterial or fungal respiratory tract infection at the time of the clinical worsening of sinusitis;\n\n(12) being in an immunocompromised state as specified at the time of the clinical worsening of sinusitis;\n\nNote: immunocompromised state as specified is defined in the Schedule 1 - Dictionary. \n\n(13) having a specified medical condition at the time of the clinical worsening of sinusitis;\n\nNote: specified medical condition is defined in the Schedule 1 - Dictionary.\n\n(14) undergoing a course of therapeutic radiation for cancer, where the nasal cavity and paranasal sinuses were in the field of radiation, before the clinical worsening of sinusitis;\n\n(15) smoking at least one pack-year of cigarettes, or the equivalent thereof in other tobacco products, before the clinical worsening of sinusitis, and:\n\n(a) smoking commenced at least one year before the clinical worsening of sinusitis; and\n\n(b) where smoking has ceased, the clinical worsening of sinusitis has occurred within three months of smoking cessation;\n\nNote: pack-year of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary. \n\n(16) being exposed to second-hand smoke:\n\n(a) for at least 1 000 hours before the clinical worsening of sinusitis; and\n\n(b) where the first exposure to second-hand smoke commenced at least one year before the clinical worsening of sinusitis; and\n\n(c) where the last exposure to second-hand smoke occurred within the three months before the clinical worsening of sinusitis;\n\nNote: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary. \n\n(17) inhaling a drug or irritant substance which results in:\n\n(a) acute nasal symptoms or signs within 48 hours of the inhalation; and\n\n(b) scarring or erosion of the nasal or sinus mucosa;\n\nbefore the clinical worsening of sinusitis;\n\nNote 1: Examples of drugs include cocaine, lidocaine, methylphenidate and narcotics.\n\nNote 2: Examples of irritant substances include gases (ammonia, chlorine, mustard, nitrogen dioxide, sulphur dioxide), powdered solids (aspirin, baking soda, levamisole, capsules, tablets, pills) and lewisite.\n\nNote 3: Examples of acute nasal symptoms or signs include rhinorrhoea, and the inflammation, oedema, ulceration or haemorrhage of the nasal mucosa.\n\n(18) for sinusitis affecting the maxillary sinus only, having a specified dental condition affecting the tissues adjacent to the affected maxillary sinus at the time of the clinical worsening of sinusitis;\n\nNote: specified dental condition is defined in the Schedule 1 - Dictionary. \n\n(19) for sinusitis with nasal polyps only, using a drug belonging to the nonselective (COX-1 and COX-2 inhibitors) nonsteroidal anti-inflammatory class of drugs, at the time of the clinical worsening of sinusitis;\n\nNote: Nonselective (COX-1 and COX-2 inhibitors) nonsteroidal anti-inflammatory class of drugs:\n\n(a) includes drugs such as aspirin, diclofenac, ibuprofen, indomethacin, ketoprofen, ketorolac, mefanamic acid, paracetamol, piroxicam and sulindac; and\n\n(b) excludes drugs such as celecoxib, etoricoxib, meloxicam and parecoxib.\n\n(20) inability to obtain appropriate clinical management for sinusitis.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factors set out in subsections 9(10) to 9(20) apply only to material contribution to, or aggravation of, sinusitis where the person's sinusitis was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(3) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary \n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\n being exposed to second-hand smoke means being in an enclosed space and inhaling smoke from burning tobacco products or smoke that has been exhaled by a person who is smoking.\n\n chronic renal failure means:\n\n(a) having a glomerular filtration rate of less than 15 mL/min/1.73 m2 for a period of at least three months; or\n\n(b) a need for renal replacement therapy (dialysis or transplantation) for treatment of complications of decreased glomerular filtration rate which would otherwise increase the risk of morbidity and mortality; or\n\n(c) undergoing chronic dialysis.\n\n immunocompromised state as specified means a condition of substantially lowered immune function, such as would occur in the following conditions or circumstances:\n\n(a) being treated with an immunosuppressive drug;\n\n(b) having a haematological or solid organ malignancy;\n\n(c) having chronic renal failure;\n\n(d) having infection with human immunodeficiency virus;\n\n(e) having severe malnutrition; or\n\n(f) undergoing solid organ, stem cell or bone marrow transplantation.\n\nNote: chronic renal failure and immunosuppressive drug are also defined in the Schedule 1 - Dictionary.\n\n immunosuppressive drug means a drug or an agent which results in substantial suppression of immune responses.\n\nNote: Examples of an immunosuppressive drug include corticosteroids other than inhaled or topical corticosteroids, drugs used to prevent transplant rejection, tumour necrosis factor-α inhibitors and chemotherapeutic agents used for the treatment of cancer.\n\n impaired drainage of the sinus means one of the following which leads to a narrowing or obstruction of the affected sinus or sinus opening:\n\n(a) an anatomical deformity including deviated septum, enlarged turbinates, adenoidal hypertrophy, fracture of the facial bones and any other bony structural abnormalities;\n\n(b) a soft tissue abnormality or mucosal swelling affecting the sinus including polyps, tumours, inflammation, sarcoidosis, granulomas and scarring; or\n\n(c) a foreign body including fungal balls, nasal packing, nasogastric or nasotracheal tubes, and dental detritus.\n\n MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n pack-year of cigarettes, or the equivalent thereof in other tobacco products means a calculation of consumption where one pack-year of cigarettes equals 20 tailor-made cigarettes per day for a period of one calendar year, or 7 300 cigarettes. One tailor-made cigarette approximates one gram of tobacco or one gram of cigar or pipe tobacco by weight. One pack-year of tailor-made cigarettes equates to 7.3 kilograms of smoking tobacco by weight. Tobacco products mean cigarettes, pipe tobacco or cigars, smoked alone or in any combination.\n\n relevant service means:\n\n(a) eligible war service (other than operational service) under the VEA;\n\n(b) defence service (other than hazardous service and British nuclear test defence service) under the VEA; or\n\n(c) peacetime service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n sinusitis—see subsection 7(2).\n\n specified dental condition means one of the following conditions:\n\n(a) displaced tooth or tooth fragments;\n\n(b) endosseous implants;\n\n(c) infected dental (apical or dentigerous) cyst;\n\n(d) maxillary trauma;\n\n(e) non-vital tooth;\n\n(f) oro-antral fistula;\n\n(g) periapical abscess;\n\n(h) periapical granuloma; or\n\n(i) periodontitis.\n\n specified medical condition means one of the following:\n\n(a) allergic rhinitis;\n\n(b) asthma;\n\n(c) diabetes mellitus;\n\n(d) gastro-oesophageal reflux disease; or\n\n(e) sinus barotrauma.\n\n terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\n VEA means the Veterans' Entitlements Act 1986.\n\n \n\n \n","sortOrder":0}],"analysis":{"kimi_summary":{"content_quality":"ok","complexity_score":5,"scope_assessment":{"changed":false,"description":"This instrument maintains the established scope of Repatriation Medical Authority Statements of Principles. It replaces the 2010 version (No. 10 of 2010) with updated medical criteria but does not expand beyond the original purpose of determining service connection for sinusitis claims. The structure — covering both onset and aggravation with defined medical factors — follows the standard template for these instruments."},"complexity_factors":["20 distinct factors with multiple sub-conditions and temporal requirements (e.g., 'at least one year before' and 'within three months of cessation')","12 defined terms in Schedule 1, several with nested definitions (e.g., 'immunocompromised state as specified' refers to 'chronic renal failure' and 'immunosuppressive drug', which are separately defined)","Parallel structure requiring careful tracking: factors 1-9 apply to 'clinical onset', factors 10-18 mirror these for 'clinical worsening', plus two unique factors (19-20) for worsening only","Cross-references to external classification systems (ICD-10-AM Tenth Edition) and other Statements of Principles for related conditions","Specific quantitative thresholds: 1,000 hours second-hand smoke exposure, 7,300 cigarettes = 1 pack-year, 7.3kg tobacco weight equivalent, glomerular filtration rate <15 mL/min/1.73 m²","Conditional logic in section 10(2) restricting factors 10-20 to aggravation cases where sinusitis pre-existed service","Drug classification complexity in factor 19 distinguishing selective vs non-selective COX inhibitors with specific examples"],"plain_english_summary":"This instrument sets the medical test for when sinusitis is treated as service-related for veterans and current/former defence members, using a \"balance of probabilities\" standard. It names specific medical and exposure factors (e.g., smoking, respiratory infection, immune suppression, radiation, inhaled toxins, dental issues) that, if linked to service, support compensation claims.\n\nIt matters because it governs taxpayer-funded compensation, replaces a 2010 version, and tightens timing and causation rules for when service can start or worsen sinusitis."},"flash_summary":{"complexity_score":6,"scope_assessment":{"changed":true,"description":"This 2018 Statement of Principles retains the original purpose—setting a medical test for connecting sinusitis to relevant service—but expands and clarifies the scope of factors compared with a generic earlier form. Concretely it: (a) explicitly includes death from sinusitis tied to a terminal event (Section 7(5)); (b) separates factors relevant to clinical onset from those relevant to clinical worsening/aggravation and lists 20 separate factors (Section 9); (c) inserts precise numeric thresholds and timing windows (pack‑year definition and timing rules in 9(6) and Schedule 1; 1,000‑hour second‑hand smoke threshold in 9(7) and Schedule 1); (d) adds an inability to obtain appropriate clinical management as a factor (9(20)); and (e) specifies immunocompromised states and examples of inhaled drugs/irritants and dental/medical conditions in Schedule 1. These additions and precisions broaden the evidentiary paths by which a claimant can establish connection to service and increase the instrument’s operational detail compared with the prior 2010 SOP (repealed by Section 4)."},"complexity_factors":["20 listed causal/aggravation factors in Section 9, split between factors at clinical onset (9(1)–9(9)) and factors for clinical worsening/aggravation (9(10)–9(20))","Approximately 14 defined terms and technical definitions in Schedule 1 (e.g. impaired drainage, immunocompromised state, pack‑year calculation, specified dental and medical conditions, terminal event)","Multiple timing and quantitative thresholds (e.g. smoking must have commenced ≥1 year before onset; cessation‑to‑onset/worsening windows of 3 months; ≥1,000 hours for second‑hand smoke exposure)","Cross‑references to other legislation and SOPs (subsection 196B(3) of the VEA; application under section 120B VEA and section 339 MRCA; Section 11 defers to other SOPs where relevant)","Dual causal concepts (material contribution/causation at onset vs material contribution/aggravation for pre‑existing disease) in Section 10(2)","Specific medical examples and exclusions within notes (e.g. lists of NSAID drugs included/excluded in 9(19)), increasing interpretive detail","Subjective factors that require discretionary assessment (e.g. inability to obtain appropriate clinical management in 9(20))","Replaces and updates a prior SOP (2010), adding new or more specific criteria which require cross‑comparison for legacy cases (Section 4)"],"plain_english_summary":"**What this instrument does (mechanics)\n\n- This is a Statement of Principles (SOP) for sinusitis that the Repatriation Medical Authority issued for use in assessing veteran and Defence-member claims under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA) (see Sections 3 and 5). It replaces an earlier 2010 SOP (Section 4).\n\n- The SOP defines what ‘sinusitis’ means for the purpose of claims (Section 7(2)) and expressly includes death from sinusitis where the disease contributed to a terminal event (Section 7(5)). It also states that, on the available medical evidence, it is more probable than not that sinusitis can be connected to relevant service (Section 8).\n\n- The core of the instrument is a list of factors. At least one of those factors must be present (and related to the person’s relevant service) before it can be concluded, on the balance of probabilities, that the sinusitis (or death from it) is connected with service (Sections 9 and 10).\n\n- The factors cover events or characteristics present at the time of the clinical onset of sinusitis (Sections 9(1)–9(9)) and, separately, factors present at the time of clinical worsening where the condition existed before or during service and was aggravated by service (Sections 9(10)–9(20)).\n\n- The instrument supplies precise definitions and thresholds for several terms used in the factors (Schedule 1). Examples include: what counts as impaired sinus drainage, what an \"immunocompromised state\" includes, how a pack‑year of smoking is calculated, the 1,000‑hour threshold for second‑hand smoke exposure, and a list of specified dental and medical conditions.\n\nWho is affected\n\n- Primary effect: veterans and current or former members of the Australian Defence Force who lodge claims for sinusitis (or death contributed to by sinusitis) under the VEA or MRCA (Section 5).\n\n- Decision‑makers: medical panels, assessors and decision-makers within the Department of Veterans’ Affairs (and medical advisers who apply SOPs) use this SOP as the medical‑scientific basis for determining whether a diagnosed sinusitis is connected with a person’s relevant service (Sections 8–11).\n\nWhy it matters (practical consequences)\n\n- The SOP establishes the medical causal/connective rules that gate access to service‑related entitlements for sinusitis claims. If a claimant can show a listed factor that is related to their relevant service, that supports a finding of connection to service (Sections 9 and 10).\n\n- Because the SOP sets measurable thresholds and lists specific circumstances (for example, a smoking history of at least one pack‑year with timing rules, or at least 1,000 hours of second‑hand smoke exposure), it shapes the type of evidence claimants must provide (see Schedule 1 and Sections 9(6)–9(7)).\n\nExplicit purpose claims and an operational test of those claims\n\n- The SOP asserts that, based on available medical evidence, sinusitis can be related to relevant service (Section 8). That is a factual premise used to justify including sinusitis on the list of service‑connected conditions.\n\n- Trade‑offs, implementation costs and behavioural effects to note:\n - Evidence burden and documentation: the SOP’s specified thresholds (e.g. 1,000 hours of second‑hand smoke, pack‑year calculation, timing windows for smoking cessation) create concrete evidentiary requirements claimants must meet. This increases the need for contemporaneous medical records, occupational histories or witness statements (Sections 9 and Schedule 1).\n - Measurement and proof difficulties: some criteria are hard to verify objectively (for example, proving total hours of second‑hand smoke exposure or demonstrating \"inability to obtain appropriate clinical management\" under factor 9(20)). These raise implementation risk and may increase discretionary decision‑making by assessors (Section 9(20), Schedule 1 definition of being exposed to second‑hand smoke).\n - Allocation of costs: where the SOP leads to finding a condition service‑connected, costs of care or compensation fall to veterans’ entitlements (government programs) rather than to the individual or other insurers. The SOP does not itself create payments; it supplies the medical test used in entitlement decisions (Sections 5, 8 and 9).\n - Behavioural incentives: the inclusion of timing rules (e.g. smoking must have commenced at least one year before clinical onset; cessation‑to‑onset windows) may change how claimants and clinicians frame histories. It could also prompt record keeping around exposures and treatments.\n - Interaction with other SOPs: if a listed factor is actually an injury or disease covered by another SOP, that other SOP applies (Section 11). This means causation can be determined under a different SOP’s terms, increasing cross‑reference complexity.\n\nWho pays, who decides, what changes in behaviour\n\n- Who pays: the SOP does not itself pay benefits. Rather, if applied and satisfied, it supports decisions that may lead to DVA (or MRCA scheme) expenses for medical care or compensation.\n- Who decides: claim assessors, medical panels and decision makers within the DVA (or agencies charged with applying the VEA/MRCA) use the SOP when deciding service connection (Sections 5, 8 and 11). The Repatriation Medical Authority provides the SOP as the authoritative medical‑scientific statement (Section 3).\n- Behaviour changes: claimants and clinicians will need to focus on documenting the specific factors and timing thresholds the SOP requires (evidence of infections, immunosuppression, smoking history, second‑hand smoke exposure hours, radiation fields, dental conditions, drug inhalation history, inability to access care, etc.) (Section 9; Schedule 1).\n\nConcrete mechanisms that could produce unintended consequences\n\n- The quantitative thresholds (pack‑years, 1,000 hours of second‑hand smoke, three‑month windows after cessation/exposure) can increase administrative dispute when records are thin.\n- The \"inability to obtain appropriate clinical management\" criterion (Section 9(20)) may be interpreted variably by different decision makers and clinicians, producing inconsistent outcomes.\n- Cross‑references to other SOPs (Section 11) mean that a claimant’s outcome can hinge on which SOP applies to a particular co‑existing disease, increasing legal and medical complexity.\n\nKey sections to consult quickly\n\n- What counts as sinusitis and death from sinusitis: Section 7.\n- The list of required factors and timing distinctions (onset vs worsening): Section 9.\n- Relationship to relevant service and limits on aggravation vs causation: Section 10.\n- Definitions and numeric thresholds (pack‑year, second‑hand smoke, immunocompromised states, specified dental/medical conditions): Schedule 1.\n\n"},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-sinusitis-balance-of-probabilities-no-74-of-2018","history":"/api/acts/statement-of-principles-concerning-sinusitis-balance-of-probabilities-no-74-of-2018/history","analysis":"/api/acts/statement-of-principles-concerning-sinusitis-balance-of-probabilities-no-74-of-2018/analysis","conflicts":"/api/acts/statement-of-principles-concerning-sinusitis-balance-of-probabilities-no-74-of-2018/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-sinusitis-balance-of-probabilities-no-74-of-2018/important-cases","documents":"/api/acts/statement-of-principles-concerning-sinusitis-balance-of-probabilities-no-74-of-2018/documents"}}